Form 8-K Genesis Healthcare, Inc. For: Feb 16
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P, Nasdaq drop on tech selloff as concerns about hawkish Fed, AI spending mount
- Chip stocks plunge, but bargain-hunters stem losses in other tech names
- Oil prices steady as investors focus on Hormuz flows after peace talks
- South Korea leveraged ETF crisis sparks global chip selloff
- Trump announces nuclear deal with Iran, lifts Hormuz blockade
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
Genesis Healthcare (GEN) Reports Q4 Revenue of $1.19B
February 19, 2015 5:36 PM ESTGenesis Healthcare (NYSE: GEN) reported Q4 loss from continuing operations of 123.23 million. Revenue for the quarter came in at $1.19 billion, versus $1.19 million reported last year.
Genesis Healthcare sees FY2015 EPS of $0.34-$0.39.
For earnings history and earnings-related data on Genesis Healthcare (GEN) click here.
... More